61
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
760265
PREVIPHARMA develops plasma-derived drugs and serves as a research partner in the plasma fractionation industry.
- Satish Kumar Devarapu: Chief Scientific Officer
- Marc Mazur: Owner & CEO
About the Company
PREVIPHARMA is a biotechnology company focused on the development of plasma-derived drugs to address unmet medical needs. It operates as a key research partner in the plasma fractionation industry, leveraging its specialized knowledge and resources to support projects across various stages. The company's expertise includes the application of
innovative techniques such as Precision Capturing® affinity resin for the capture of specific proteins like Ferritin, contributing to the advancement of plasma protein research. With a team of dedicated professionals, PREVIPHARMA aims to explore the potential of plasma proteins through early discovery to development, ensuring the delivery of valuable therapeutic solutions.
